• MK-0812 in MASH Models: Deep Mechanisms and Translational Im

  2026-05-10

  Explore MK-0812 as a potent monocyte trafficking inhibitor in metabolic dysfunction-associated steatohepatitis (MASH) research. This article provides a technical, mechanism-focused analysis and practical protocol guidance, uniquely bridging reference findings and assay design.

• ARCA Cy5 EGFP mRNA (5-moUTP): Precision in mRNA Delivery Ass

  2026-05-09

  ARCA Cy5 EGFP mRNA (5-moUTP) combines 5-methoxyuridine modification with dual fluorescence for accurate, real-time tracking of mRNA delivery, translation, and localization in mammalian cells. Its streamlined workflow, immune evasion, and direct-readout capabilities set a new benchmark for quantitative mRNA delivery system research.

• SARS-CoV-2 Nucleocapsid Protein Suppresses GADD34 Pathway

  2026-05-08

  This study uncovers how the SARS-CoV-2 nucleocapsid protein antagonizes the GADD34-mediated innate immune pathway by inducing atypical stress granule-like foci. The findings elucidate a novel viral immune evasion mechanism, providing a framework for further research on viral-host interactions and potential therapeutic strategies.

• Microfluidic Peptide/mRNA Complexes Enable Pulmonary Deliver

  2026-05-08

  This study introduces a microfluidic mixing approach to generate robust peptide/RNA complexes, enabling efficient pulmonary delivery of mRNA and siRNA via nebulisation. The findings demonstrate that cationic peptide-based vectors maintain transfection efficiency and structural integrity through aerosolisation, offering a promising non-viral alternative for lung-targeted RNA therapeutics.

• α-Amanitin: Precision RNA Polymerase II Inhibition in Resear

  2026-05-07

  α-Amanitin is a highly specific inhibitor of eukaryotic RNA polymerase II, making it indispensable for transcriptional regulation research and gene expression pathway analysis. As supplied by APExBIO (SKU A4548), its stability, potency, and precise action facilitate reproducible results in cell-based and developmental studies.

• SAR405: Precision Vps34 Inhibitor for Autophagy Research

  2026-05-07

  SAR405 enables highly selective, nanomolar-range inhibition of Vps34, making it the gold standard for dissecting autophagy and vesicle trafficking in cell biology and disease modeling. Its exquisite specificity and compatibility with diverse workflows set it apart for advanced mechanistic studies.

• Patient-Derived 3D Spheroids: A Translational Model for Pros

  2026-05-06

  This study introduces patient-derived three-dimensional spheroid cultures from radical prostatectomy tissue as a robust and versatile in vitro model for organ-confined prostate cancer. The model enables long-term viability, recapitulates tumor heterogeneity, and supports pharmacological testing, providing a significant advance for translational prostate cancer research.

• Moxidectin Potentiates Polyene Antifungals Against Oral Cand

  2026-05-06

  This study reveals that moxidectin elevates ergosterol biosynthesis in Candida albicans, thereby enhancing the antifungal efficacy of polyenes such as nystatin and amphotericin B. These findings offer a mechanistically grounded strategy to overcome certain limitations of current polyene treatments in oral candidiasis and highlight new opportunities for combination therapy.

• Dual-Action p38α MAPK Inhibitors Accelerate Dephosphorylatio

  2026-05-05

  This study uncovers how certain p38α MAPK inhibitors not only block kinase activity but also enhance phosphatase-mediated dephosphorylation by stabilizing a unique activation loop conformation. The findings reveal a new dual-action mechanism with potential to improve specificity and potency in kinase-targeted research and therapeutic strategies.

• Cyclo (-RGDfC): Precision Tumor Targeting in Cell Assays

  2026-05-05

  Cyclo (-RGDfC) delivers robust, integrin αvβ3-specific targeting for advanced cancer and angiogenesis research. Its cyclic structure confers unmatched stability and specificity, enabling high-fidelity cell adhesion, migration, and drug delivery workflows. Discover how APExBIO’s peptide empowers reproducible, data-driven experimental design.

• WM-8014 as a Precision KAT6A Inhibitor for Cancer Biology

  2026-05-04

  WM-8014 enables highly selective, non-cytotoxic induction of cell cycle arrest and senescence, making it a standout tool for dissecting KAT6A/B dependencies in cancer biology and epigenetic research. This guide delivers protocol enhancements and troubleshooting strategies, bridging state-of-the-art CRISPR screening insights with hands-on assay optimization.

• Forsythoside E: Workflow Innovations for PKM2 Inhibitor Rese

  2026-05-04

  Forsythoside E revolutionizes sepsis-induced liver injury research by precisely modulating PKM2 and macrophage polarization. Explore robust experimental protocols, troubleshooting insights, and unique comparative advantages for translational immunometabolism.

• Cy5-UTP (Cyanine 5-UTP): Single-Molecule RNA Dynamics and Pr

  2026-05-03

  Explore how Cy5-UTP (Cyanine 5-uridine triphosphate) enables advanced single-molecule RNA conformation studies and ultra-precise RNA probe labeling. Discover unique technical protocols, mechanistic insights, and practical guidance not found in standard application guides.

• Myriocin as a Serine Palmitoyltransferase Inhibitor in Resea

  2026-05-02

  Myriocin, a selective serine palmitoyltransferase inhibitor, empowers precise control of sphingolipid biosynthesis in cancer, immunology, and metabolism research. Its nanomolar potency and robust in vivo efficacy enable reproducible workflows and novel mechanistic insights, as recently demonstrated in post-myocardial infarction remodeling studies.

• Microfluidic Peptide/RNA Complexes Enable Pulmonary mRNA Del

  2026-05-01

  This study demonstrates the use of cationic peptides and microfluidic mixing to form robust RNA complexes suitable for pulmonary delivery by nebulisation. The innovation preserves transfection efficiency after aerosolisation, offering a non-viral alternative for mRNA and siRNA therapeutics targeting lung diseases.

16140 records 1/1076 page Next 12345 下5页 Last page